Clinical Trial Update: Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery

View source ↗

Summary

A completed clinical trial investigates prognostic factors in patients with stage II colon cancer treated with tegafur-uracil after complete surgical removal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Tegafur-Uracil (tegafur-uracil)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Colorectal Cancer | Status: COMPLETED